The Allstate Corporation (ALL) is down 3.2% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears tied to renewed sensitivity around catastrophe-loss exposure after the company’s recent monthly catastrophe-loss disclosure and reinsurance program updates. In addition, recent analyst note activity (including at least one price-target cut and a prior downgrade) may be contributing to a softer near-term sentiment and profit-taking.
Details:
Sources:
Allstate Investor Relations, SEC (EDGAR), StreetInsider
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$ALL Insider Trading Activity
$ALL insiders have traded $ALL stock on the open market 38 times in the past 6 months. Of those trades, 0 have been purchases and 38 have been sales.
Here’s a breakdown of recent trading of $ALL stock by insiders over the last 6 months:
- THOMAS J WILSON (Chairman, President & CEO) has made 0 purchases and 28 sales selling 134,456 shares for an estimated $28,028,562.
- SUREN GUPTA has made 0 purchases and 5 sales selling 46,600 shares for an estimated $9,926,204.
- JESSE E MERTEN has made 0 purchases and 4 sales selling 33,986 shares for an estimated $7,088,485.
- MARIO RIZZO sold 18,578 shares for an estimated $4,064,866
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ALL Hedge Fund Activity
We have seen 777 institutional investors add shares of $ALL stock to their portfolio, and 760 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FRANKLIN RESOURCES INC added 3,014,768 shares (+60.2%) to their portfolio in Q1 2026, for an estimated $624,494,117
- GQG PARTNERS LLC added 1,452,993 shares (+36.0%) to their portfolio in Q4 2025, for an estimated $302,440,492
- QUBE RESEARCH & TECHNOLOGIES LTD removed 879,495 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $182,182,991
- PRICE T ROWE ASSOCIATES INC /MD/ removed 872,988 shares (-7.5%) from their portfolio in Q1 2026, for an estimated $180,835,099
- ALLIANZ ASSET MANAGEMENT GMBH added 821,832 shares (+304.8%) to their portfolio in Q1 2026, for an estimated $170,238,389
- GOLDMAN SACHS GROUP INC added 780,193 shares (+38.1%) to their portfolio in Q1 2026, for an estimated $161,613,078
- MENORA MIVTACHIM HOLDINGS LTD. removed 742,598 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $153,825,462
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ALL Analyst Ratings
Wall Street analysts have issued reports on $ALL in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 02/11/2026
- Roth Capital issued a "Buy" rating on 11/26/2025
To track analyst ratings and price targets for $ALL, check out Quiver Quantitative's $ALL forecast page.
$ALL Price Targets
Multiple analysts have issued price targets for $ALL recently. We have seen 11 analysts offer price targets for $ALL in the last 6 months, with a median target of $240.0.
Here are some recent targets:
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $266.0 on 05/07/2026
- Elyse Greenspan from Wells Fargo set a target price of $243.0 on 05/06/2026
- Paul Newsome from Piper Sandler set a target price of $268.0 on 05/01/2026
- Matthew Heimermann from Citigroup set a target price of $226.0 on 05/01/2026
- Alex Scott from Barclays set a target price of $208.0 on 04/08/2026
- Yaron Kinar from Mizuho set a target price of $265.0 on 03/20/2026
- Ryan Tunis from Cantor Fitzgerald set a target price of $220.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.